Research Article
Predictors of Visual Response to Intravitreal Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
Table 4
Multivariate analysis of visual acuity score change (letters) from baseline at 6 months.
| ||||||||||||||||||||||||||||||||||||||||
AMD: age-related macular degeneration; SE: standard error; VA: visual acuity. Variables included in step 1 are age group, gender, baseline VA score, duration of neovascular AMD, ARMS2 rs10490924 genotype, and treatment regimen. |